Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.

Clicks: 195
ID: 64932
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #293 of 436 articles by views in Trials

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 436 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Following publication of the original article [1], the authors notified us of a few requested editions that were not implemented adequately during proofing. The publisher apologizes for the inconvenience caused to our authors and readers.
Reference Key
villar2019correctiontrials Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Villar, Juan Carlos;Herrera, Víctor Mauricio;Carreño, Juan Guillermo Pérez;Herrera, Eliana Váquiro;Domínguez, Yeny Zulay Castellanos;Vásquez, Skarlet Marcell;Cucunubá, Zulma Milena;Prado, Nilda Graciela;Hernández, Yolanda;
Journal Trials
Year 2019
DOI
10.1186/s13063-019-3630-y
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.